Does tranexamic acid reduce risk of mortality on patients with hemoptysis?: A protocol for systematic review and meta-analysis

BACKGROUND: Although tranexamic acid (TXA), a readily accessible antifibrinolytic agent, is widely adopted in hemorrhage scenarios, its role on mortality in patients with hemoptysis remains uncertain. New evidence is yet to be generated to evaluate the risk of mortality after using TXA in patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Liang-Fu, Wang, Ting-Cheng, Lin, Ting-Yi, Pao, Po-Jia, Chu, Karen Chia-Wen, Yang, Chih-Hao, Chang, Jer-Hwa, Hsu, Chin-Wang, Bai, Chyi-Huey, Hsu, Yuan-Pin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
3900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137080/
https://www.ncbi.nlm.nih.gov/pubmed/34011056
http://dx.doi.org/10.1097/MD.0000000000025898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137080/
https://www.ncbi.nlm.nih.gov/pubmed/34011056
http://dx.doi.org/10.1097/MD.0000000000025898

Ejemplares similares